We report the isolation of a novel human POU domain encoding gene named RDC-1. The POU domain of the RDC-1 encoded protein is highly related to the POU domain potentially encoded by the rat brain-3 sequence and to that of the Drosophlla I-POU protein; outside of the POU region, RDC-1 is unrelated to any previously characterized protein. The RDC-1 gene is expressed almost exclusively in normal tissues and transformed cells of neural origin. In the developing mouse and human fetus, RDC-1 is expressed in a spatially and temporally restricted pattern that suggests a critical role in the differentiation of neuronal tissues. In addition, RDC-1 is expressed in a unique subset of tumors of the peripheral nervous system including neuroepitheliomas and Ewing's sarcomas but not neuroblastomas. Based on its unique structural characteristics and expression pattern, we discuss potential functions for the RDC-1 protein.
INTRODUCTION
Efforts to elucidate the complex set of interactions governing mammalian development have been aided by studies of development in lower eukaryotes. Genetic analysis of a variety of developmental mutants of Drosophila has resulted in the identification of a family of genes, all containing a homeodomain, that are critical for pattern formation and differentiation in the developing fly (for review see 1). Homeodomains are conserved throughout eukaryotic evolution and the identification of mammalian genes encoding homeodomain proteins has led to speculation that these genes play a similar role in pattern formation and cell lineage determination in mammalian development (2) .
A subset of homeodomain containing proteins shares additional conserved sequences adjacent to the homeodomain and these additional sequences plus the homeodomain are collectively referred to as a POU domain. The POU domain was originally identified in Pit-1, a pituitary specific transcription factor (3); Oct-2, a lymphoid specific factor able to activate transcription of immunoglobulin genes (4); Oct-1, a ubiquitously expressed factor capable of activating transcription of small nuclear RNA genes and histone H2B genes (5); and unc86, a genetically identified cell lineage and differentiation gene (6) . The precise functional role of the POU-specific regions A and B is unclear, although these sequences do seem to contribute to the DNA binding specificity of the homeodomain (7, 8) .
We report here the identification of a gene, RDC-1, encoding a novel human POU domain containing protein. Examination of expression in developing mammals and human tumors reveals a highly restricted pattern of expression that appears confined primarily to cells and tissues derived from the neural crest. In addition, the RDC-1 gene product has regions of remarkable evolutionary conservation. Together, these findings suggest that RDC-1 functions in a fundamental and highly conserved cellular process involved with cell lineage determination and differentiation.
MATERIALS AND METHODS
Isolation of genomic and cDNA clones RDC-1 was isolated from human placental DNA on the basis of hybridization to DNA probes derived from exons 2 and 3 of human N-myc (9) . EcoRI-digested genomic DNA from human placenta was used to construct a library in the lambda phage Charon 35A. Hybridizations, were carried out under reduced stringency conditions in 37% formamide-5xSSCPE (0.6 M NaCl, 0.075 M sodium citrate, 0.05 M potassium phosphate, 0.05 M EDTA), 10% dextran sulfate, 1 xDenhart's solution, and 100 micrograms salmon sperm DNA per ml at 42°C. The 12-kb RDC-1 locus was subcloned into the EcoRI site of pVcos7, an expression vector containing a Moloney murine leukemia virus long terminal repeat, and transfected into primary rat embryo fibroblasts according to published procedures (10) . Doublestranded cDNA was constructed from poly(A) + RNA derived from the transfected cells as described (11) . The cDNA was made blunt-ended by treatment with the Klenow fragment of E. coli DNA polymerase, ligated to EcoRI linkers, and cloned into the EcoRI site of lambda gtlO. This library was hybridized with a 0.55-kb Styl-Xhol fragment derived from the genomic RDC-1 locus to identify a partial (0.5-kb) RDC-1 cDNA clone, denoted 36A. A second cDNA library was constructed from poly(A) + RNA derived from the CHP100 neuroepithelioma cell line using a Pharmacia cDNA cloning kit according to the manufacturer's instructions. Approximately 10 6 recombinant clones were screened with the 0.5-kb EcoRI insert derived from the previously identified 36A cDNA clone. Multiple overlapping cDNA clones were identified were subcloned into Bluescripts SK-and two overlapping clones pNE7 and pNElO, were selected for further analysis.
DNA senquence analysis of RDC-1
The plasmids pNE7 and pNElO were subjected to DNA sequence determination. However, because these cDNA clone lacked approximately 600 bp at the 5' end of the RDC-1 transcript two adjacent Pst fragments of 0.9-and 0.85-kb size derived from the RDC-1 genomic locus (see Figure 1A) transcript start site and 5' end of the transcript were contained on these two Pst fragments (data not shown). Nested deletions were generated using the ExoIH-Mung Bean nuclease system (Stratagene) and direct subcloning into M13 vectors mpl8 and mpl9 was used to generate appropriately sized fragment for sequencing. M13 single-stranded DNA or denatured plasmid DNA was sequenced using a Sequenase kit (US Biochemical Corp.).
RNA analysis
Total RNA was prepared by the guanidinium thiocyanate method of RNA extraction. Poly (A) + RNA was prepared by passage over oligo(dT)-cellulose (Boehringer-Manheim). For Northern blotting RNA was fractionated on 1 % agarose gels containing 2.2 M formaldehyde, transferred to nitrocellulose membranes, baked at 80°C for 1 -2 hours and hybridized with nick-translated probes as previously described (Kohl et al. 1983 ). DNA probes include: (1) a 0.5-kb EcoRI fragment from partial cDNA clone 36A comprising a portion of the 3' untranslated region of the RDC-1 transcript (for the Northern blots in Figure 1C 
SI, protection analysis
For SI nuclease analysis of human RNA samples a 336-bp TaqI fragment from the 3' untranslated region of the RDC-1 cDNA (nucleotides 1870 to 2206 in Figure 2 A) was subcloned into the M13 vector mpl8 and uniformly labelled with [ 32 P]dATP according to published procedures (12) . A single-stranded DNA probe was hybridized to RNA, treated with SI nuclease, and electrophoresed through a 5% denaturing acrylamide gel as previously described (9) .
Chromosomal mapping of RDC-1
Isolation, propagation, and characterization of most parental cells and somatic cell hybrids used in this study have been described (13, 14, 15) . The presence of specific human chromosomes or regions of chromosomes has been confirmed by DNA hybridization using probes for genes assigned to specific human chromosome regions. Two probes were used to detect the RDC-1 locus: pR36.4, containing the genomic EcoRI fragment shown in Figure 1 A, and pNE7, a partial RDC-1 cDNA. Chromosome 13 specific probes used include pi 11/17 at 13q21-q31 (13) and three 13-linked anonymous probes (16) p7F12 (D13S1) at 13ql2-ql3, p9Dll (D13S2) at 13q22, and p9A7 (D13S3) at 13q32-33 (these probes generously provided by Webb Cavanee). The RDC-1 probes hybridized to a human specific fragment in the following cell lines: 77-5, CSK-12, BD3, cll3, 2S9, cll3 6TG, and GL5D, all of which contained chromosome 13 or a portion of chromosome 13. Hybridization of RDC-1 probes to a human specific fragment was not found in any of the following cell lines: cl21, GB31, cll7, N9, B2, cl2, PB5-5, AA3, GL3k, cl20, S2, 3a, which all lack chromosome 13. Scoring for hybridizaton of RDC-1 probes to the somatic cell hybrids localized RDC-1 to a region of 13q.
RESULTS

Identification of the RDC-1 genomic locus
DNA probes derived from exons 2 and 3 of N-myc were used to screen a human genomic library under reduced stringency conditions (9) . Several recombinant clones were identified in this way. One such clone, denoted RDC-1, contained a 12-kb EcoRI fragment ( Figure 1A ) and is therefore distinct from previously characterized myc family genes. Additional analysis of the Nmyc homologous regions of RDC-1 demonstrated that these regions were short in size but similar enough to N-myc to account for cross-hybridization (data not shown); however, this homology appeared fortuitous as no significant similarities were encoded at the protein level (data not shown).
Southern blot hybridization analyses carried out under normal stringency conditions demonstrated that a DNA probe derived from RDC-1 detects both a 12 kb EcoRI fragment and an additional higher molecular weight fragment in human DNA ( Figure IB , lane H; two distinct fragments were seen using a variety of restriction enzymes, data not shown). Furthermore, hybridizing fragments were also detected in mouse, canary, xenopus, and Drosophila DNA under normal stringency conditions, indicating a high degree of evolutionary conservation ( Figure IB, lanes M, C, X, D) .
RDC-1 encodes unique transcripts
The evolutionary conservation of RDC-1 suggested that the gene might encode a factor important for a conserved cellular function. Therefore, to assay for expression of RDC-1, total cellular RNA from 12 human tumor samples or cell lines (representing various cell types) was examined by Northern blot analysis using an RDC-1 DNA probe. In this analysis, hybridizing transcripts were detected only in RNA of the CHPIOO neuroepithelioma cell line; two transcripts of approximately 4.0-and 2.0-kb were observed ( Figure 1C; lane 11) . To further characterize the RDC-1 transcripts, a cDNA library constructed from poly A + RNA from CHPIOO was screened and clones that hybridized to the RDC-1 probe were isolated.
RDC-11 contains a POU domain
We determined the nucleotide structure and deduced amino acid codon sequence of the cDNA corresponding to the 4. The POU domain of RDC-1 is highly related to all previously identified POU proteins, although it is most closely related to those of the C.elegans unc-86 gene (84% identical; 6), the brn-3 POU domain isolated from rat brain (100% identical; 17), and the recently described Drosophila I-POU protein (83% identical; 18). The similarity between RDC-1 and brn-3 extends into the spacer region separating the B domain from the homeodomain whereas most of the differences between RDC-1 and I-POU are found in this spacer region. Outside of the POU domain RDC-1 is completely dissimilar to unc-86 and I-POU; however, because only the POU domain of brn-3 has been isolated, a complete analysis of the structural relationship between RDC-1 and brn-3 is not possible.
Outside of the POU domain RDC-1 contains an unusually high number of alanine and glycine residues and in this way resembles the POU transcription factor SCIP, isolated from the rat peripheral nervous system (19) and the Drosophila POU proteins Cfl-a and pdm-1 (20; 21). The alanine and glycine residues are scattered throughout the proteins and do not form any discrete domains conserved between these three proteins. Furthermore, RDC-1 contains a polyhistidine stretch (residues 15 to 23) similar to stretches found in pdm-1 and a Cfl-a related Drosophila clone (21). Common region pne7,pR3 6.6 13 Figure 5 . Regional localization of RDC-1 on chromosome 13. DNA from rodent-human hybrids retaining portions of chromosome 13 were tested for hybridization to RDC-1 specific probes after cleavage with HindlD or EcoRI restriction enzymes. Hybrid cl 13 6TG is a daughter clone of hybrid cll3 which was selected in 6-thioguanine to selectively eliminate hybrids retaining the der 11 (11 pter-llq22::Xq24-Xqter). Hybrid cll3 carries a fragment of chromosome 13 (13) , the extent of which we have determined using 13 specific DNA probes as shown in the figure; the dashed portion of the line is to indicate that it is uncertain exactly where the break in 13 lies. Hybrid 2S9 retains a partial 13 defined by molecular markers. Since each of these hybrid DNAs retain the locus for RDC-1, this gene must map to the portion of 13 which is common to both hybrids, namely 13ql4-q22.
RDC-1 is expressed in a tissue-and stage-specific manner during development Because homeo-box containing proteins are known to play a critical role in pattern formation and development in Drosophila and are thought to play a similar role in mammals, we examined the expression of RDC-1 during human and murine development.
To assay for tissue-and stage-specific expression of RDC-1, total RNA was isolated from a variety of human fetal tissues at 15 weeks and 24 weeks gestational age and analyzed by Northern blot hybridization to an RDC-1 probe. This probe identified the 4.0-and 2.0-kb RDC-1 transcripts in 15-week brain, spinal cord, and eye and in 24-week eye ( Figure 3A) . The expression of RDC-1 in these three neurogenic tissues contrasted sharply with its absence in various tested non-neurogenic tissues including the adrenal, heart, liver, kidney, and thymus. To analyze RDC-1 developmental expression patterns in more detail, we analyzed RDC-1 expression in developing murine tissues. The RDC-1 probe detected transcripts of approximately 3.5-and 2.5-kb in RNA from the brain and spinal cord of day 13.5 mouse embryos ( Figure 3B : E13.5, Br and SQ. Expression in these two tissues gradually decreased to almost undetectable levels in the 7 day old mouse (Figure 3B : P7, Br and SQ and was not detected in RNA from brain and spinal cord at later stages ( Figure 3B : P14, P21, and P28). RDC-1 transcripts were not detectable in any other tissues assayed at various embryonic and postnatal ages including heart, liver, kidney, intestine, and thymus. Expression of RDC-1 in the developing mouse parallels the observed expression in human development in that RDC-1 is expressed exclusively in tissues with neural characteristics during a limited period of embryonic and early postnatal life.
Expression of RDC-1 is limited primarily to certain cells with neuroendocrine characteristics To confirm the apparently restricted pattern of RDC-1 RNA expression observed by Northern analyses of tumor cell RNA (Figure 1) , poly A + RNA from various tumor samples and normal tissues was tested for RDC-1 expression by a more sensitive SI nuclease protection assay using a probe derived from the RDC-1 cDNA. Consistent with Northern blotting analyses, SI nuclease assays readily detected RDC-1 transcripts in RNA from the CHP100 neuroepithelioma cell line ( Figure 4A) . However, most other tested samples including normal placenta, adult liver, adult adrenal, adult kidney, melanoma, and one lung tumor tested failed to show detectable RDC-1 transcripts ( Figure  4A ). We did detect RDC-1 transcripts in RNA from the H510 small cell lung tumor line, the U937 macrophage line, and an uncharacterized colon tumor. In total, RDC-1 expression was detected in only 4 of 24 RNA samples assayed representing at least 17 different cell lineages ( Figures 1C and 4A and data not shown). Two of the samples expressing RDC-1 are from tissues thought to arise from the neural crest: CHP100 and H510 (22, 23) .
Several POU homeodomain proteins including the Drosophila proteins I-POU and Cfl-a are also expressed predominantly in tissues of neural origin. These two proteins appear to be intimately involved in determining the type of neurotransmitter produced by neurons by regulating the expression of the dopadecarboxylase gene (encoding an enzyme required by adrenergic neurons; 18). In this regard, we have assayed for RDC-1 expression in neuroepitheliomas and neuroblastomas, two histologically similar tumors of the human peripheral nervous system that respectively produce cholinergic and adrenergic neurotransmitters (23, 24) . Total RNA from 8 different neuroepithelioma and 8 different neuroblastoma tumor cell lines was isolated and assayed for expression of RDC-1 by Northern blotting analysis. RDC-1 transcripts were readily detected in 6 out of 8 neuroepithelioma samples ( Figure 3D, lanes 2-8, 13 ), but were not detected in any of eight neuroblastomas samples ( Figure 3D, lanes 1, 12,  14, 18-22) , showing that RDC-1 generally is expressed in the cholinergic tumor lines but not in the adrenergic ones.
Ewing's sarcomas display a number of neural features including the production of cholinergic neurotransmitters (25) and are characterized by an t(ll;22) chromosomal translocation (26) . Because of these neural features and because an identical t(l 1 ;22) translocation is found in neuroepitheliomas (27) , RNA from several Ewing's sarcoma cell lines was tested for expression of RDC-1. Total RNA was prepared from 6 Ewing'ssarcoma samples and assayed by Northern blot hybridization for RDC-1 expression. RDC-1 transcripts were readily detectable in 4 of 6 Ewing's sarcoma samples tested ( Figure 3D , lanes 9 -11, 15-17) .
RDC-1 maps to human chromosome 13
Although RDC-1 is expressed in a limited set of human tumors, the gene is expressed in two different tumor types that contain a t(l 1 ;22)(q23 -24;ql 1 -12) chromosomal translocation. To determine if RDC-1 might be directly involved in this translocation, we mapped the chromosomal location of this gene. DNA from twenty five rodent-human hybrids and a mouse and human control were analyzed by Southern blotting with hybridization to probes derived from the RDC-1 genomic and cDNA clones. Hybrid DNAs which were positive or negative for the RDC-1 homologous fragments were scored and indicated that RDC-1 is located on chromosome 13 (see Materials and Methods). To regionally localize the RDC-1 locus more precisely, two hybrids retaining partial chromosomes 13 (as defined by the presence or absence of 13-linked molecular markers) were screened for hybridization to RDC-1 probes. These data (summarized in Figure 5 ) demonstrate that the common chromosome region present in the positive hybrids is chromosome region 13ql4-q22. A narrower localization to 13q22 has recently been defined using other hybrids carrying partially deleted chromosomes 13 (M.Hansen, W. Cavenee, and K Huebner, unpublished observations). Therefore RDC-1 is located in chromosome region 13ql4-q22 and is not directly involved in the t(ll;22) chromosomal translocation.
DISCUSSION
We have isolated a novel human gene, RDC-1, that encodes a POU domain protein. Although the POU domain encoded by RDC-1 shows striking similarity to three well-characterized transcriptional activators-Pit-1, Oct-1, and Oct-2 (3, 4, 5)-its POU-encoded region is most closely related to those of the unc-86 gene, the recently described Drosophila I-POU protein, and the brn-3 nucleotide sequence. The unc-86 gene encodes a C.elegans protein of unknown function (6) while the brn-3 POU sequence was derived from the rat genome by PCR (17) and has not yet been identified as part of a distinct gene. The I-POU protein is a putative dominant, negative transcriptional inhibitor that blocks activation by Cfl-a, a positive POU-domain regulator of neuronspecific genes (18) .
The high degree of similarity between the POU domains of RDC-1 and unc-86, despite the large evolutionary distance separating the species from which these genes originate, may reflect a highly conserved functional role played by these two genes. Unc-86 is intimately involved in cell lineage determination and differentiation of the nervous system of C.elegans. Homozygous unc-86 loss of function mutants have specific nervous system defects including the absence of certain types of neurons and the failure to differentiate other neuronal cell types. Because RDC-1 is expressed specifically in embryonic tissues that give rise to neural structures, it also may play such a role in cell lineage determination and differentiation in humans.
We have isolated and determined the nucleotide sequence of the RDC-1 hybridizing Drosophila gene and found that it was identical to I-POU (M.Data, R.Collum, and F.Alt, unpublished). However, the homology resided completely within the POU domain, and outside of this region RDC-1 and I-POU are completely dissimilar. The negative regulatory activity of I-POU is ascribed to the lack of two critical basic amino acid residues within the POU domain (18) . These two residues are retained within the RDC-1 POU domain. Therefore, it seems very unlikely that RDC-1, despite the fact that I-POU appears to be the closest Drosophila relative, would have an I-POU like negative regulatory property.
N-terminal to the POU domain the RDC-1 protein is characterized by glycine-alanine rich regions and a polyhistidine stretch. In this way, RDC-1 resembles a number of POU proteins from other species that appear to play a role in nervous system development. These proteins include pdm-1, Cfl-a, and a Cfl-a related clone from Drosophila and SCIP from the rat (19, 20, 21) . The potential function of these regions in POU domain proteins particularly in relation to neural development remains speculative.
Although some POU domain encoding genes are expressed ubiquitously (5), most POU domain genes have a more limited pattern of expression (3, 17) . RDC-1 resembles the latter group of genes in that its expression is highly restricted during development and in tumor cells. In this regard, the RDC-1 and brn-3 sequences have highly related POU domains and are both expressed primarily in neural tissues. However, within neural tissues, the expression patterns of these two sequences are quite distinct. Levels of brn-3 RNA increase during embryonic development to reach their highest levels at embryonic day 18 (in the rat) with continuing expression into adulthood (17) ; while RDC-1 expression, on the other hand, peaks early during embryogenesis (day El3.5) and is undetectable by 14 days after birth ( Figure 3B ).
RDC-1 is expressed in the developing brain, spinal cord, and eye during a limited period of active growth and differentiation. Although the precise cell types that express RDC-1 within these tissues have not been established, the expression patterns of RDC-1 both in vivo and in tumor cell lines strongly implicate this gene in the development of certain cells of neural crest origin. In this regard, the common expression of RDC-1 in neuroepitheliomas and Ewing's sarcomas supports the notion that these two tumors share a common developmental lineage and/or function (25) . Although RDC-1 is expressed specifically in cells and tissues with neuronal characteristics, it is not expressed in all neuronal or neuronal-like cells tested. Indeed, the expression of RDC-1 in peripheral neuroepitheliomas versus the morphologically similar neuroblastomas should provide an important marker for further distinguishing them. Furthermore, the expression of RDC-1 correlates with the type of neurotransmitter produced by these tumors: neuroepitheliomas are cholinergk and neuroblastomas are adrenergic (23) . Notably, the Drosophila I-POU and Cfl-a POU domains proteins also are expressed predominantly in tissues of neural origin where they may be intimately involved in regulating the adrenergic neuronspecific dopa-decarboxylase gene (18) . Given the restricted expression of RDC-1 in cholinergic versus adrenergic neural tumors and and the strong homology to I-POU, it seems possible that RDC-1 also may play a role in the regulation of specific gene expression within a subset of neuronal lineages.
